Track topics on Twitter Track topics that are important to you
For over 35 years, NAMSA has been supporting the medical device and pharmaceutical industries through a wide variety of testing services, all designed to ensure safety, efficacy and regulatory compliance. As a privately owned and managed company, we are completely focused on our clients needs and the quality of our testing and consulting services. Our technical staff members understand the complex compliance requirements of the FDA, European Notified Bodies, the Japanese Ministry of Health and Welfare and other regulatory agencies worldwide. We work with our clients to develop individualized testing programs, guiding them through the simplest test or the most complex development project. We also provide guidance through the submission and regulatory approval process. Our technical specialists provide accurate reports and supporting data that is easy to understand and presented in ways that are preferred by regulatory bodies. And we provide services to interpret test results and identify and discuss problems that may occur at any point during the product development process.
6750 Wales Road
United States of America
NAMSA, the world’s leading medical research organization, is pleased to announce the addition of Microbiological Compliance Laboratories (MCL) as NAMSA’s local agent in Costa Rica
NORTHWOOD, OH--(Marketwired - November 03, 2015) - NAMSA, the world's leading medical research organization is pleased to announce the addition of Blanchard & Associates as NAMSA's local agent in ...
Crosstex to acquire NAMSA’s Products Division to grow global sales of Sterilization Products in the industrial market North American Science Associates, Inc. (NAMSA), the wo...
NAMSA replaced its paper-based system for managing clinical trial documents with Veeva Vault eTMF and has reported that eTMF has reduced the time spent handling files by at least one-third. Dat...
Macclesfield-based Cyprotex has acquired a business in the US. The contract research organisation has purchased the business and assets of CeeTox Inc, a division of North American Science Associates ...
TORONTO, ON--(Marketwired - February 08, 2016) - Industry expert Sandra Welch, Director of Clinical Research Services at NAMSA, will examine the requirements listed in MEDDEV 2.7.1 rev. 3 while focusi...
NAMSA Replaces Manual, Paper-based System to Transform Its TMF into a True Strategic Asset NAMSA, a leading global medical research organization, partnered with Veeva S...
LITTLE FALLS, N.J., March 2, 2016 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN), today announced that the company has successfully completed the previously disclosed acquisition of NAMSA's Sterilit...
For over 35 years, NAMSA has been supporting the medical device and pharmaceutical industries through a wide variety of testing services, all designed to ensure safety, efficacy and regulatory complia...
EAU Technologies, Inc. (EAU) is a supplier of Electrolyzed Water Technology (EW Technology marketed as Empowered Water(TM)) and other complementary technologies with applications in diverse industries...
We have published hundreds of NAMSA news stories on BioPortfolio along with dozens of NAMSA Clinical Trials and PubMed Articles about NAMSA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NAMSA Companies in our database. You can also find out about relevant NAMSA Drugs and Medications on this site too.
The role of medical devices in healthcare is essential. The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare. Covering a wide range of products, from simple bandages to the...